Clinical Trial Update: Biomarkers of Bone Resorption in Metastatic Prostate Cancer

View source ↗

Summary

The University of Aberdeen completed a clinical trial evaluating biomarkers of bone resorption in metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Aberdeen | Conditions: Metastatic Prostate Cancer | Status: COMPLETED